Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis

Method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis

US Patent 7247302 · Granted Jul 24, 2007

Estimated economic value: $89,078,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant BR96 antibodies reactive with human carcinomas1998
Mutant BR96 antibodies reactive with human carcinomas1998
Mutant BR96 antibodies reactive with human carcinomas1998
Mutant BR96 antibodies reactive with human carcinomas1998
Diagnostic test for Pseudomonas aeruginosa infections1998
Monoclonal antibody compositions cross-reactive and cross-protective against P. 1997
Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactiv1997
Monoclonal antibodies cross-reactive and cross-protective against human monoclon1997
Monoclonal antibodies cross-reactive and cross-protective against P. aeruginosa 1995
Monoclonal antibodies to pseudomonas aeruginosa flagella1989